AKT1 and endothelial dysfunction: Wang F. showed that CTRP3 can reduce the production of inflammatory factors and the number of cell losses induced by high glucose in HUVEC by activating the AKT-mTOR pathway, suggesting that CTRP3 may play a role in diabetes-related endothelial dysfunction (Wang et al., 2019).